CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces Scheduled Release of Q2 2020 Results, Conference Call

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) on Monday announced that it will release its second quarter 2020 results after the close of markets on Friday, August 14, 2020. According to the update, senior management will host a conference call to discuss the results at 11 a.m. ET on Monday, August 17, 2020. Interested parties may join the call by dialing 647-427-7450 or 1-888-231-8191 and entering conference ID: 8762205. Participants may register for and log into the live webcast at http://cnw.fm/JH267. The webcast will be archived for 90 days.

To view the full press release, visit http://cnw.fm/NJvdA

About VIVO Cannabis(TM)

VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms(TM), Beacon Medical(TM), Fireside(TM), Fireside X(TM), Lumina(TM) and Canadian Bud Collection(TM). The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The Company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information visit www.VIVOCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Rhode Island Licenses First Lab to Test Marijuana Potency

Rhode Island legalized medical cannabis back in 2006, and it became one of the first states with a cannabis dispensary system when it introduced the system in 2009. As of 2020, there are 3 cannabis dispensaries in the state; Thomas C. Slater Compassion Center in Providence, Summit Medical Compassion Center in Warwick, and Greanleaf Compassion Center in Portsmouth. But Rhode Island’s medical marijuana program differed greatly from programs in other states.

For years, the state had not licensed any laboratories to test for marijuana potency. Either the growers in Rhode Island tested their own products, dispensaries tested the marijuana themselves or they contracted unlicensed, private labs. Finally, the Rhode Island Department of Health (“RIDOH”) has licensed a lab to test the marijuana produced by licensed growers and distributed at dispensaries for medical use in the state. Green Peaks Analytical, which has been testing cannabis products, water, and soil for environmental compliance since 1976, was awarded the license.

Patients will now have access to unbiased, third-party data on the potency of their medical marijuana. “Like all other patients in Rhode Island, people who use medical marijuana deserve to have access to safe medication, and they deserve to have accurate information about that medication. The increased oversight that RIDOH and DBR will be providing will help ensure that critical product safeguards are in place for medical marijuana patients,” says director of Rhode Island’s health department Nicole Alexander-Scott.

Over the course of six weeks, the Rhode Island Department of Business Regulations’ (“DBR”) Office of Cannabis Regulation will gather feedback from Green Peaks Analytical, licensed growers, compassion centers. The information the office gathers will be used by the DBR to establish a deadline after which all medical marijuana products in the state will be required to have labeling that displays potency totals verified by a licensed laboratory. The two departments will also work with licensed laboratories using a phased approach to create a certification that includes testing for contaminants, such as metals, pesticides, or solvents.

The state’s medical cannabis regulators have also started accepting applications for up to six additional cannabis dispensaries. However, unlike the three existing dispensaries which are vertically integrated and grow their own crop, the six new dispensaries will be required to buy their marijuana from the six currently licensed cultivators in the state. The licenses will be issued through a lottery process with one license for each of the six geographical zones. Applicants have until December 15 to submit their applications.

Sectors players like Pure Extracts Corp. may be surprised to learn that for all this long, Rhode Island didn’t have a licensed lab to test the cannabis products being purchased by patients in the state.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Opponents File Lawsuit against Arizona Marijuana Ballot Measure

At the start of the year, at least 10 states had plans to legalize either medical or recreational cannabis. But as the coronavirus took hold, lawmakers didn’t have enough time to discuss comprehensive marijuana reforms. This, coupled with the shutdown and social distancing measures, meant states like New York and Ohio had to postpone their legalization plans. In Arizona, however, activists were able to collect enough signatures to get marijuana legalization on the November ballot, but they are now facing another potential hurdle.

A group opposed to legal cannabis has filed a lawsuit arguing that the initiative used deceptive language when collecting signatures and is asking a Maricopa County Superior Court judge to declare the initiative invalid. The lawsuit was filed by Arizonians for Health and Public Safety. It claims that the sponsors of the initiative did not adequately describe the measure in a 100-word summary that was included in the petition that voters signed. The group argues that the summary should have included or at least expanded on a number of the details contained in the 16-page initiative.

The lawsuit argues that the summary should have made it clear to voters that legalizing marijuana under the proposed initiative would also legalize marijuana concentrate. “The proponent’s summary of the initiative is confusing and deceptive in numerous ways, beginning with the very definition of marijuana,” says former Congressman John Shadegg, one of the attorneys who filed the lawsuit.

Additionally, the lawsuit states that the summary’s claim that the initiative would “protect employer and property owner rights” is misleading as well. The group also argues that the summary should have explained how governments could not tax marijuana on top of the proposed 16% rate. The lawsuit also states that the 100-word summary should have better explained how Arizonians under the age of 21 caught in possession of marijuana won’t receive felony charges. The initiative would set the legal age for possession at 21 and make underage marijuana possession a civil penalty.

According to Lisa James, Chairwoman of political action committee Arizonians for Health and Public Safety, “these omissions and statements misled voters who signed the petition about what the initiative would do.” However, Stacy Pearson, spokeswoman for the initiative campaign Smart and Safe Arizona, states that the lawsuit is without merit and only underscores what opponents would have wanted the 100-word summary to say, not what it was required to say. In 2018, the state Supreme Court ruled that although the 100-word summary of an initiative must state the initiatives ‘primary provisions’, it does not need to be impartial and does not need to detail every provision of a ballot measure.

Additionally, “there’s no way to incorporate a 15-page document or a 12-page document into a 100-word summary,” says Pearson. “We’re not particularly concerned and certainly the court has, over the years, favored direct democracy.”

Analysts say cannabis industry players like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) will be interested in seeing how this legal battle pans out, as the outcome could reshape how ballot measures are drafted in future.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Congress Passes Measure Allowing Military Personnel to Use CBD

When the 2018 Farm Bill legalized industrial hemp and its derivatives, no one knew just how big cannabidiol (“CBD”) would get. Flush with medical properties, CBD has quickly become a go-to compound for people seeking a natural alternative to pharmaceuticals. However, despite being federally legalized, several military branches have in the past few months issued statements stating that service members were not permitted to use CBD products. In response, Rep. Tulsi Gabbard, a military veteran, and former 2020 Democratic presidential candidate sponsored an amendment that would allow military service members to use products containing hemp and its derivatives.

Approved by the House of Representatives on Monday, the amendment stipulates that the “Secretary of Defense may not prohibit, on the basis of a product containing hemp or any ingredient derived from hemp, the possession, use or consumption of such a product by a member of the Armed Forces.” This is only applicable as long as the crop meets the federal definition of hemp (less than 0.3% THC) and “such possession, use, or consumption is in compliance with applicable Federal, State, and Local law.”

Gabbard’s amendment will address notices from several military branches instructing their service members to abstain from using CBD. For instance, the Department of Defense (DOD) announced a policy barring all active service members from using hemp products, including CBD, in February. The DOD acknowledged that while hemp was legal, the risk of exposure to excess THC was too great.

The Air Force and the Navy as well have informed their members that they are barred from using hemp-derived CBD, no matter its legality. Although NASA isn’t part of the military, it has also warned its employees that CBD products could contain excess levels of THC that could cost them their job if they fail a drug test. This aversion to CBD products can be traced back to a July 24 government wide-memo asking agencies to update their employees about CBD.

The notice by the Substance Abuse and Mental Health Services Administration (“SAMHSA”) stated that although the 2018 Farm Bill legalized hemp-derived CBD, “the Food and Drug Administration does not certify levels of THC in the products. The agency stated that due to the lack of regulatory oversight from the FDA, “federal workers and those with security clearances who test positive for THC metabolites will be penalized, regardless of whether they thought they were taking CBD alone.”

Rep. Gabbard’s amendment was passed in an en bloc passage including dozens of other non-cannabis amendments to the National Defense Authorization Act (“NDAA”), and it has been attached to the House version of the NDAA.

Cannabis sector players like Pure Extracts Corp. are probably waiting to see the fate of the amendment once it gets to the floor of the U.S. Senate.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – FDA Finally Releases Cannabis Research Guidelines

In December 2018, Congress passed the 2018 Farm Bill, a landmark legislation that legalized the cultivation and sale of industrial hemp and it’s derivatives after decades of prohibition. Cannabidiol, a hemp extract with medical capabilities, quickly grew in popularity, resulting in an unregulated market worth millions of dollars in sales. For months, advocates, stakeholders, and some lawmakers have urged the U.S. Food and Drug Administration (“FDA”) to create a comprehensive regulatory structure for the industry.

On Tuesday, the agency finally released draft guidance on developing cannabis-based drugs, weeks after the White House announced that it had finished reviewing the draft guidance. The published document states that the guidance is “limited to the development of human drugs and does not cover other FDA regulated products.” As the FDA is still developing guidelines that would allow CBD to be marketed and sold as a food item or supplement, the draft document is meant to provide guidance for drug manufacturing.

“A range of stakeholders have expressed interest in the development of drugs that contain cannabis and other compounds found in cannabis. Recent legislative changes have also opened new opportunities for cannabis clinical research. As that body of research progresses and grows, the FDA is working to support drug development in this area,” says FDA Principal Deputy Commissioner Amy Abernethy. The legislative change she refers to is the 2018 Farm Bill which legalized industrial hemp with less than 0.3% THC. Thus, researchers can use industrial hemp from any source as long as it doesn’t have excess THC, not just from the University of Mississippi, the country’s only federally authorized marijuana manufacturer.

The new document stresses on THC testing, stating that sponsors and investigators may find it useful to calculate the level of delta-9 THC in their proposed investigational drug product early in the development process to gain insight into the potential control status of their product. “Regardless of whether cannabis or a cannabis-derived compound meets the definition of hemp, sponsors and applicants should work with reliable laboratories for analytical testing.”

It also gives step by step guidance on how to test for THC on a dry weight basis according to the FDA’s standards. In a Federal Register notice accompanying the new draft guidance, the agency asked for comments from the public on their recommended approach to testing for THC. The FDA has opened a 60-day comment period for stakeholders to offer their opinions on the proposed research guidelines.

It would be great to hear what the initial reactions of entities like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) are regarding the research guidelines published by the FDA.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Activists Put Pressure on Mexican Lawmakers to Legalize Recreational Marijuana

The past few years have been great for cannabis. Advanced research into its effects on the body that has found it has plenty of medical benefits, coupled with changing attitudes towards the plant, have pushed it more into the mainstream. As a result, plenty of territories have passed legislation allowing either recreational or medical marijuana within their borders. Many more jurisdictions have cannabis legalization on the books or they are at least considering it.

In Mexico, activists have demanded that the Senate include the legalization of recreational cannabis in the next special session that starts on July 29. This comes after the Mexican Cannabis Movement accused the Senate of possible contempt of a 2018 ruling by the Supreme Court of Justice of the Nation (“SCJN”). The court ruled that an absolute ban on the recreational use of marijuana was unconstitutional and gave Congress until December 15 to regulate public consumption of marijuana. However, according to activists, legislators have consistently failed to do that.

“We see constant delay, a delay in this legislation, now there is already one more extension, until Dec 15, and there is a Senator who wants to postpone the ruling even more under the excuse of the COVID-19 pandemic,” says Leopoldo Rivera, coordinator of the movement. They are holding a demonstration in front of the Senate in downtown Mexico City, where they have planted 420 marijuana plants of up to 2.5 meters tall. The activists want legislators to pass a law that upholds four core values: free personal or associated cultivation, simple free possession, dignified treatment, and public spaces for safe, responsible, and regulated consumption.

“We decided to start this movement of planting weed, and planting ourselves as citizens, as users of cannabis and as responsible citizens against a law that clearly does not do justice, that clearly criminalizes, that is clearly useless,” Rivera says. This March, the senate discussed a marijuana regulation law that would allow people to possess up to 28 grams of marijuana, and wouldn’t criminalize cultivating or using cannabis for medical purposes. However, it was met with opposition from activists who claimed it did not comply with the ruling by the SCJN and favored the interests of private companies.

“We’ve been here more than five months and only four months and only four senators have come down. Who do they legislate for? What they are proposing is a cosmetic change, which is not going to solve the problems of unconstitutionality pointed out by the Supreme Court,” says Rivera, adding that the Supreme Court shouldn’t grant any extensions to the Mexican Senate. “The police are mistreating the people, they are mistreating us, they are mistreating the citizens, they arrest them even when they are not consumers to extort them, to deprive them of their freedom, and that goes against the Mexican constitution.”

It would be interesting to hear what thoughts cannabis companies like Sugarmade, Inc. (OTCQB: SGMD) have about the bumpy ride that marijuana legalization is taking despite a categorical ruling from the Supreme Court of the country about the topic.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Third-Party Presidential Nominees Push for Marijuana Legalization

With everything that’s been going on for the past six months, from a global pandemic that’s crippled the economy to the protests against police brutality raging across the country, it’s easy to forget that the November ballot is fast approaching. The ballot may very well be a turning point for the cannabis industry. For starters, the Democratic Party made it clear that if it clinches Congress and the White House this coming November, it will make decriminalizing marijuana one of its top priorities, despite presumptive Democratic presidential nominee Joe Biden’s views on the matter.

The presidential nominees for both the Libertarian and Green Parties also support broader drug reform, including legalizing marijuana. During an interview with C-SPAN this month, Libertarian pick Jo Jorgensen said that the biggest problem we have right now isn’t drugs but drug prohibition. “Now, do drugs and alcohol cause problems? Of course, they do. However, they’d be much more manageable if it were legal. What’s the difference between me drinking bourbon in my home and somebody else smoking marijuana in their own home? If there is no victim, there is no crime,” she says.

In a statement released on Twitter, she said that the U.S. prison population jumped from 350,000 to 2.3 million in just 30 years due to ‘Draconian sentence lengths, mandatory minimums, and an increase in the number of drug laws which creates more ‘crimes’.” Ending the failed drug war would be a top priority if elected as it has led to the highest incarceration rate in the world. On day 1, I would pardon ALL nonviolent, victimless offenders in federal prison. If there was no victim, there is no crime.”

During a speech delivered remotely for the Green Party National Convention, Green nominee Howie Hawkins said that drug reform could be a tool to combat mass incarceration. “We’ve got to treat drug abuse as a health problem. You should legalize marijuana and decriminalize the hard drugs like Portugal did. Instead of just throwing people in prison and building the biggest prison industrial system in the world, which Joe Biden had a lot to do with as he wrote the legislative architecture for that as chair of the Senate Judiciary Committee, we should be treating drug addiction as a health problem, not a criminal problem.”

“One of the central changes to policing is to end the war on drugs. 20% of incarcerated people in the U.S. are locked up due to a drug offense. We need to legalize marijuana, decriminalize other drugs, and make treatment readily available like Portugal did.”

Industry watchers say cannabis sector players like VIVO Cannabis Inc. (TSXV: VIVO) (OTCQX: VVCIF) may not put a lot of stock in what these other presidential nominees say since they don’t command a huge following among voters, and can hardly sway the direction of drug policy at the federal level.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Announces Publication of New 8K Highlighting Specific BudCars Investment Information

Sugarmade (OTCQB: SGMD), today announces the publication of a new Form 8K Current Report filing (the “8K”) with the United States Securities and Exchange Commission (the “SEC”). According to the update, the 8K highlights specific information about the Company’s investment position in Indigo Dye Group, Inc., which conducts business as a cannabis delivery service under the name “BudCars.” The 8K also contains current information about the performance of BudCars in terms of gross receipts from operations during the three months ended June 30, 2020.

To view the full press release, visit http://cnw.fm/82Kvr

About Sugarmade, Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. More information on Sugarmade can be accessed at: www.Sugarmade.com. Sugarmade sees opportunities in business operations that combine the best areas of on-demand consumer distribution with certain areas of synergistic manufacturing and packaging to create a business model that capitalizes on the many changes in the cannabis industry. The company has made agreements with several market participants, which will be announced in 2020. The company views these opportunities as scalable and capable of producing strong revenue growth for the company.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Enters Estimated $10B Cannabis Market Through Strategic Agreement with Whisper Weed

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced the closing of a definitive agreement to enter the fast-growing California cannabis delivery market. According to the update, Whisper Weed, Inc. and Cannabis Global have, under the executed agreement, created a new California Corporation to be named CGI Whisper W, Inc., which will provide management services for the delivery entity. CGI Whisper W, Inc, will receive 51% of the new entity’s profits, which will be recognized by Cannabis Global as income. “The delivery sector is the hottest area of the California cannabis business and we are very pleased to have a seat at the table,” Arman Tabatabaei, CEO of Cannabis Global, stated in the news release. “We not only will be able to grow our revenue base relative to direct delivery, but we also see Whisper Weed as a perfect platform to launch our infusion technologies in the regulated marketplace. With the deal closing, we are already in the process of adding other delivery platforms and other businesses to our overall portfolio.”

To view the full press release, visit http://cnw.fm/rwedO

About Cannabis Global, Inc.

Cannabis Global is a Nevada registered, fully reporting and audited publicly traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the Company’s website at www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – What Current Research Says About Marijuana and Memory

We all know the stereotype of the bumbling, forgetful stoner. Cannabis has for long been associated with memory loss, and that has been one of the main arguments against legalizing. However, most of these claims lacked any scientific backing but over the past few years, researchers have been steadily learning more about cannabis and its effect on the human body, especially the brain. To understand how cannabis affects memory, we’ll first have to discuss short and long term memory.

Your short term memory stores immediate events temporarily, for instance, to remember a phone number that has just been recited. It can hold information for approximately twenty to thirty seconds, and it is pushed out when new items are presented. Long term memory, on the other hand, stores information indefinitely. Research has shown that marijuana intoxication does have an effect on short term memory, temporarily altering or distorting short term memory processing.

However, this can’t be blamed on ‘cannabis’ as a whole. The plant produces hundreds of chemicals called cannabinoids, and they are responsible for its effects. In this case, the cannabinoids in question are THC (delta-9 tetrahydrocannabinol) and cannabidiol (“CBD”). When you consume cannabis, these two components disrupt neural signaling by binding with receptors responsible for forming memories in the brain. This can result in problems with concentration, loss of interest, and eventually impact learning.

What’s interesting is that the two cannabinoids have quite different effects. THC, the chemical responsible for cannabis’ infamous high, has a negative effect on short term memory and it increases the risk of developing mental health problems. Cannabidiol, on the other hand, has been found to prevent neural decline. It has a positive impact against neurodegenerative diseases that affect memory such as psychosis, Alzheimer’s, Huntington Chorea, and epilepsy. In fact, some animal studies found that it could prevent the onset of these diseases through the creation of neurons.

There are several different cannabis strains, each with varying levels of CBD and THC, and they have different effects on memory. For instance, cannabis with high levels of THC but little to no CBD will have a negative effect on memory, especially in adolescents. It impacts their ability to retain and recall information, but this isn’t permanent and will stop once you stop consuming cannabis. However, a strain with high CBD levels can prevent neural decline. This goes to show that different types and strains of cannabis can have both positive and negative effects on memory.

The cannabis sector, including entities like Sugarmade, Inc. (OTCQB: SGMD), are glad that the myths against cannabis are being dismantled one at a time by solid scientific data.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.